Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia - PubMed (original) (raw)
. 2011 Jan 18;19(1):138-52.
doi: 10.1016/j.ccr.2010.12.012.
Emanuele Marchi, Ann Atzberger, Lynn Quek, Anna Schuh, Shamit Soneji, Petter Woll, Adam Mead, Kate A Alford, Raj Rout, Salma Chaudhury, Amanda Gilkes, Steve Knapper, Kheira Beldjord, Suriya Begum, Susan Rose, Nicola Geddes, Mike Griffiths, Graham Standen, Alexander Sternberg, Jamie Cavenagh, Hannah Hunter, David Bowen, Sally Killick, Lisa Robinson, Andrew Price, Elizabeth Macintyre, Paul Virgo, Alan Burnett, Charles Craddock, Tariq Enver, Sten Eirik W Jacobsen, Catherine Porcher, Paresh Vyas
Affiliations
- PMID: 21251617
- DOI: 10.1016/j.ccr.2010.12.012
Free article
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia
Nicolas Goardon et al. Cancer Cell. 2011.
Free article
Abstract
The relationships between normal and leukemic stem/progenitor cells are unclear. We show that in ∼80% of primary human CD34+ acute myeloid leukemia (AML), two expanded populations with hemopoietic progenitor immunophenotype coexist in most patients. Both populations have leukemic stem cell (LSC) activity and are hierarchically ordered; one LSC population gives rise to the other. Global gene expression profiling shows the LSC populations are molecularly distinct and resemble normal progenitors but not stem cells. The more mature LSC population most closely mirrors normal granulocyte-macrophage progenitors (GMP) and the immature LSC population a previously uncharacterized progenitor functionally similar to lymphoid-primed multipotential progenitors (LMPPs). This suggests that in most cases primary CD34+ AML is a progenitor disease where LSCs acquire abnormal self-renewal potential.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment in
- Human acute myelogenous leukemia stem cells revisited: there's more than meets the eye.
Majeti R, Weissman IL. Majeti R, et al. Cancer Cell. 2011 Jan 18;19(1):9-10. doi: 10.1016/j.ccr.2011.01.007. Cancer Cell. 2011. PMID: 21251611 Free PMC article.
Similar articles
- Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Quek L, Otto GW, Garnett C, Lhermitte L, Karamitros D, Stoilova B, Lau IJ, Doondeea J, Usukhbayar B, Kennedy A, Metzner M, Goardon N, Ivey A, Allen C, Gale R, Davies B, Sternberg A, Killick S, Hunter H, Cahalin P, Price A, Carr A, Griffiths M, Virgo P, Mackinnon S, Grimwade D, Freeman S, Russell N, Craddock C, Mead A, Peniket A, Porcher C, Vyas P. Quek L, et al. J Exp Med. 2016 Jul 25;213(8):1513-35. doi: 10.1084/jem.20151775. Epub 2016 Jul 4. J Exp Med. 2016. PMID: 27377587 Free PMC article. Clinical Trial. - The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R, Rempel E, Manta L, Saeed BR, Wang W, Raffel S, Ermakova O, Eckstein V, Benes V, Trumpp A, Ho AD, Lutz C. Blume R, et al. Leuk Lymphoma. 2018 Sep;59(9):2201-2210. doi: 10.1080/10428194.2017.1422862. Epub 2018 Jan 16. Leuk Lymphoma. 2018. PMID: 29334844 - High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
Daga S, Rosenberger A, Quehenberger F, Krisper N, Prietl B, Reinisch A, Zebisch A, Sill H, Wölfler A. Daga S, et al. Cancer Med. 2019 Apr;8(4):1771-1778. doi: 10.1002/cam4.2053. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30848055 Free PMC article. - Cancer stem cells in hematological disorders: current and possible new therapeutic approaches.
Annaloro C, Onida F, Saporiti G, Lambertenghi Deliliers G. Annaloro C, et al. Curr Pharm Biotechnol. 2011 Feb 1;12(2):217-25. doi: 10.2174/138920111794295747. Curr Pharm Biotechnol. 2011. PMID: 21044004 Review. - Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
Hoang VT, Zepeda-Moreno A, Ho AD. Hoang VT, et al. Biotechnol J. 2012 Jun;7(6):779-88. doi: 10.1002/biot.201100350. Epub 2012 May 16. Biotechnol J. 2012. PMID: 22588704 Review.
Cited by
- FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors.
Mead AJ, Kharazi S, Atkinson D, Macaulay I, Pecquet C, Loughran S, Lutteropp M, Woll P, Chowdhury O, Luc S, Buza-Vidas N, Ferry H, Clark SA, Goardon N, Vyas P, Constantinescu SN, Sitnicka E, Nerlov C, Jacobsen SE. Mead AJ, et al. Cell Rep. 2013 Jun 27;3(6):1766-76. doi: 10.1016/j.celrep.2013.04.031. Epub 2013 May 30. Cell Rep. 2013. PMID: 23727242 Free PMC article. - Physioxia enhances T-cell development ex vivo from human hematopoietic stem and progenitor cells.
Shin DY, Huang X, Gil CH, Aljoufi A, Ropa J, Broxmeyer HE. Shin DY, et al. Stem Cells. 2020 Nov;38(11):1454-1466. doi: 10.1002/stem.3259. Epub 2020 Aug 15. Stem Cells. 2020. PMID: 32761664 Free PMC article. - RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
Crews LA, Balaian L, Delos Santos NP, Leu HS, Court AC, Lazzari E, Sadarangani A, Zipeto MA, La Clair JJ, Villa R, Kulidjian A, Storb R, Morris SR, Ball ED, Burkart MD, Jamieson CHM. Crews LA, et al. Cell Stem Cell. 2016 Nov 3;19(5):599-612. doi: 10.1016/j.stem.2016.08.003. Epub 2016 Aug 25. Cell Stem Cell. 2016. PMID: 27570067 Free PMC article. - Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia.
van Gils N, Denkers F, Smit L. van Gils N, et al. Front Oncol. 2021 May 3;11:659253. doi: 10.3389/fonc.2021.659253. eCollection 2021. Front Oncol. 2021. PMID: 34012921 Free PMC article. Review. - Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 Inhibition.
Cai SF, Chu SH, Goldberg AD, Parvin S, Koche RP, Glass JL, Stein EM, Tallman MS, Sen F, Famulare CA, Cusan M, Huang CH, Chen CW, Zou L, Cordner KB, DelGaudio NL, Durani V, Kini M, Rex M, Tian HS, Zuber J, Baslan T, Lowe SW, Rienhoff HY Jr, Letai A, Levine RL, Armstrong SA. Cai SF, et al. Cancer Discov. 2020 Oct;10(10):1500-1513. doi: 10.1158/2159-8290.CD-19-1469. Epub 2020 Jun 30. Cancer Discov. 2020. PMID: 32606137 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- G0801073/MRC_/Medical Research Council/United Kingdom
- G1000729/MRC_/Medical Research Council/United Kingdom
- G84/6443/MRC_/Medical Research Council/United Kingdom
- MC_U137973817/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases